Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
3.090
-0.290 (-8.58%)
At close: Jun 3, 2026, 4:00 PM EDT
3.110
+0.020 (0.64%)
After-hours: Jun 3, 2026, 7:14 PM EDT
Cellectis Market Cap
Cellectis has a market cap or net worth of $227.37 million as of June 3, 2026. Its market cap has increased by 99.10% in one year.
Market Cap
227.37M
Enterprise Value
123.59M
1-Year Change
99.10%
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $227.37M, a decrease of -83.08%. That is a compound annual growth rate of -14.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 245.40M | -29.91% |
| Dec 31, 2025 | 350.10M | 169.72% |
| Dec 31, 2024 | 129.80M | -24.18% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
| Mar 25, 2015 | 1.34B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MacroGenics | 263.14M |
| Nuvectis Pharma | 258.62M |
| Context Therapeutics | 256.34M |
| Protara Therapeutics | 254.04M |
| Adagene | 250.75M |
| Entrada Therapeutics | 248.99M |
| AC Immune | 244.03M |
| Codexis | 242.69M |